A detailed history of Alliancebernstein L.P. transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 11,820 shares of PLSE stock, worth $172,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,820
Holding current value
$172,099
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.69 - $14.54 $79,075 - $171,862
11,820 New
11,820 $132,000
Q2 2022

Aug 15, 2022

SELL
$1.48 - $4.28 $31,596 - $91,373
-21,349 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$4.21 - $14.79 $6,315 - $22,185
-1,500 Reduced 6.56%
21,349 $104,000
Q2 2021

Jul 30, 2021

BUY
$16.31 - $23.64 $16,309 - $23,640
1,000 Added 4.58%
22,849 $375,000
Q1 2021

May 06, 2021

SELL
$22.43 - $44.27 $80,748 - $159,372
-3,600 Reduced 14.15%
21,849 $517,000
Q3 2020

Nov 12, 2020

BUY
$9.27 - $13.14 $2,085 - $2,956
225 Added 0.89%
25,449 $300,000
Q2 2020

Aug 13, 2020

BUY
$6.23 - $13.09 $53,727 - $112,888
8,624 Added 51.95%
25,224 $264,000
Q1 2020

May 14, 2020

BUY
$5.23 - $15.2 $7,322 - $21,280
1,400 Added 9.21%
16,600 $119,000
Q3 2019

Nov 14, 2019

SELL
$10.73 - $17.33 $1,073 - $1,732
-100 Reduced 0.65%
15,200 $235,000
Q2 2019

Aug 14, 2019

BUY
$11.11 - $17.34 $5,555 - $8,670
500 Added 3.38%
15,300 $202,000
Q1 2019

May 14, 2019

BUY
$11.69 - $19.44 $35,070 - $58,320
3,000 Added 25.42%
14,800 $260,000
Q3 2018

Nov 08, 2018

BUY
$12.83 - $16.45 $7,698 - $9,870
600 Added 5.36%
11,800 $167,000
Q2 2018

Aug 13, 2018

SELL
$14.04 - $20.28 $9,828 - $14,196
-700 Reduced 5.88%
11,200 $170,000
Q1 2018

May 14, 2018

BUY
$12.67 - $24.69 $17,738 - $34,566
1,400 Added 13.33%
11,900 $161,000
Q4 2017

Feb 13, 2018

BUY
$18.81 - $30.33 $197,505 - $318,465
10,500
10,500 $248,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $541M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.